15733-87-6 Usage
General Description
2-Bromoquinoline-4-carboxylic acid is an organic compound classified under the chemical category of quinolines and derivatives. It is constructed with a quinoline backbone, which is a fused ring structure composed of benzene and pyridine, with a functionalized carboxylic acid and bromine atom. As a brominated quinoline, it may possess potential biological activities because many quinoline derivatives serve as interesting scaffolds in medicinal chemistry, due its potential for extensive chemical modifications. However, the specific properties and uses of 2-Bromoquinoline-4-Carboxylic Acid are not widely reported in the scientific literature. Its characteristics such as stability, reactivity, risk and safety, would need to be considered carefully in any application and further investigated by chemical testing.
Check Digit Verification of cas no
The CAS Registry Mumber 15733-87-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,7,3 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 15733-87:
(7*1)+(6*5)+(5*7)+(4*3)+(3*3)+(2*8)+(1*7)=116
116 % 10 = 6
So 15733-87-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H6BrNO2/c11-9-5-7(10(13)14)6-3-1-2-4-8(6)12-9/h1-5H,(H,13,14)
15733-87-6Relevant articles and documents
STAT3 INHIBITOR CONTAINING QUINOLINECARBOXAMIDE DERIVATIVE AS ACTIVE INGREDIENT
-
Page/Page column 61, (2011/06/24)
The present invention provides a STAT3 inhibitor containing as an active ingredient, a quinolinecarboxamide derivative represented by the formula (I) (in the formula, W represents a bond or an alkylene chain; X represents O, S, or NR34; and Rs
2-Aminoquinolinecarboxamides: neurokinin receptor ligands
-
Page column 14, (2008/06/13)
Disclosed are compounds of the formula: or pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof, wherein R1, R2, R3, X, Q1and Q2are defined herein, which compounds are ligands for neurokinin receptors, in particular NK-3 receptors, and are therefor useful in the treatment of a wide range of diseases or disorders including, but not limited to depression, anxiety, psychosis, obesity, pain, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, movement disorders, respiratory diseases, inflammatory diseases, neuropathy, immune disorders, migraine, biliary disfunction, and dermatitis.
